Somalogic stock.

SomaLogic, Inc. analysts consensus, targets, ratings and recommendations | Börse Stuttgart: 76X0 | Börse Stuttgart

Somalogic stock. Things To Know About Somalogic stock.

SomaLogic Reports Fourth Quarter and Full Year 2022 Financial Results, Announces Director Appointments and Management Evolution. ... Preferred stock, $0.0001 par value; 1,000,000 shares authorized ...SLGC Earnings Date and Information. SomaLogic last announced its earnings results on November 8th, 2023. The reported ($0.12) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.17) by $0.05. The business earned $22.05 million during the quarter, compared to analysts' expectations of $20.45 million.SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for its cognate protein; and offers proprietary SomaScan services, which provide multiplex protein detection and quantification of protein levels ...SomaLogic expects revenue for the full year 2023 to range from $82 to $85 million. Webcast and Conference Call Details. SomaLogic will host a conference call at 4:30 p.m. ET on Wednesday, November 8, 2023, to discuss its third quarter 2023 financial results. Those interested in listening to the conference call should register online here.Mar 28, 2023 · SomaLogic, Inc. (SLGC) delivered earnings and revenue surprises of 0% and 21.48%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Approximate date of commencement of proposed sale to the public: As soon as practicable after this registration statement becomes effective and all other conditions to the transactions contemplated by the Merger Agreement described in the included proxy statement/prospectus have been satisfied or waived.. If the securities being registered on …SomaLogic Inc.’s SLGC, +10.78% stock was up about 12% in premarket trades on Wednesday after the Boulder, Colo.-based specialist in cell proteins agreed to be acquired in an all-stock merger ...Standard BioTools and SomaLogic to Combine in All-Stock Merger Creating a Diversified Leader in Life Sciences Tools. GlobeNewswire 61d. Start Trading >> …

Summary of all time highs, changes and price drops for SomaLogic; Historical stock prices; Current Share Price: US$2.71: 52 Week High: US$3.79: 52 …

Somalogic story: Investors one-year losses grow to 65 percent as the stock sheds US155m this past week - Simply Wall St and other headlines for Somalogic Stock United States Sign Incommon stock and SomaLogic preferred stock held in SomaLogic’s treasury or owned by the Company, Merger Sub or SomaLogic immediately prior to the Effective Time (each an “E x c l ude d Share”), will be cancelled and no consideration will be paid or payable with respect thereto and (ii) each share of SomaLogic stock, other thanUpon the terms and subject to the conditions set forth in the Merger Agreement, at the effective time of the Merger, each share of common stock, par value $0.0001 per share, of SomaLogic issued and outstanding (“SomaLogic Stock”) will be converted into the right to receive 1.11 (the “Exchange Ratio”) shares of common stock, par value $0.001 per …SomaLogic is a leading commercial-stage proteomics company. On October 4, 2023, Standard BioTools and SomaLogic announced a merger whereby Standard BioTools will issue new shares of stock to existing SomaLogic shareholders. After the merger, which is expected to close in early 2024, current Standard BioTools …

Read by the top investment banks, management consultancies, VCs, and research houses. Trusted by over 100,000 institutional and retail investors. Covering disruptive technologies for over 18 years. SomaLogic stock is a proteomics play that claims to have a significant first-mover advantage. They're also looking to enable their tech on Illumina ...

Nov 7, 2023 · Corporate: On October 4, 2023, the Company announced an all-stock merger with SomaLogic, which is expected to build a diversified leader in life sciences tools. The Company expects to close the ...

Oct 4, 2023 · SomaLogic Inc.'s (SLGC) stock was up about 12% in premarket trades on Wednesday after the Boulder, Colo.-based specialist in cell proteins agreed to be acquired in an all-stock merger with ... Jul 26, 2022 · Under the terms of the merger agreement, SomaLogic will pay at closing $35 million, comprising $14 million in cash and $21 million in SomaLogic common stock. Up to an additional $17.5 million may be paid in connection with the achievement of certain future revenue-based milestones. Standard BioTools and SomaLogic will host a joint conference call and webcast today at 8:30 a.m. ET to discuss the merger. The conference call can be accessed by dialing (800) 225-9448 within the ...hace 8 horas ... ... SomaLogic Investor Relations at [email protected]. No Offer or ... Stock Picks. More Stock Picks · 3 Dividend Stocks for December 2023.9 oct 2023 ... Mintz is proud to represent Standard BioTools Inc. in its all-stock merger deal with SomaLogic. Our deal team was led by Matthew Gardella, ...Get the latest SomaLogic, Inc. (SLGC) stock quote, history, news and other vital information to help you with your stock trading and investing. See the performance …The SomaLogic, Inc. stock price gained 1.62% on the last trading day (Friday, 17th Nov 2023), rising from $2.47 to $2.51. During the last trading day the stock fluctuated 3.48% from a day low at $2.44 to a day high of $2.53. The price has been going up and down for this period, and there has been a 11.06% gain for the last 2 weeks.

Mar 28, 2023 · SomaLogic, Inc. is a commercial-stage proteomics company. The Company has built an integrated proteomics platform, which offers throughput proteomics analysis with broad proteome coverage. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate ... Upon the terms and subject to the conditions set forth in the Merger Agreement, at the effective time of the Merger, each share of common stock, par value $0.0001 per share, of SomaLogic issued and outstanding (“SomaLogic Stock”) will be converted into the right to receive 1.11 (the “Exchange Ratio”) shares of common stock, par value $0 ...When it comes to purchasing a new vehicle, finding the perfect car that meets all your requirements can be a daunting task. If you have your heart set on a Genesis GV70, you’ll want to ensure that you find the best one available in stock.Real time SomaLogic (SLGC) stock price quote, stock graph, news & analysis. Nov 22, 2023 · Public companies currently own 5.5% of SomaLogic stock. This may be a strategic interest and the two companies may have related business interests. It could be that they have de-merged. Endpoints News — SomaLogic, co-founder of acquired company battle in court over unvested stock News • Jun 29, 2023 Benzinga — Analyst Ratings for Concentrix

The ETF added to its position in the biotech stock earlier this month and now owns nearly 12.6 million shares, valued at close to $29 million. SomaLogic is a pioneer in proteomics, the study of ...SLGC Earnings Date and Information. SomaLogic last announced its earnings results on November 8th, 2023. The reported ($0.12) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.17) by $0.05. The business earned $22.05 million during the quarter, compared to analysts' expectations of $20.45 million.

Sep 22, 2023 · 3. SomaLogic. Wood first bought shares of SomaLogic (SLGC 3.44%) last year for her Ark Genomic Revolution ETF. The ETF added to its position in the biotech stock earlier this month and now owns ... Aug 15, 2023 · Shares of SomaLogic (SLGC-0.35%) were up more than 11% as of Tuesday at 11:15 a.m. ET. The biotech company reported second-quarter earnings after the markets closed on Monday. The healthcare stock ... Under the terms of the all-stock deal, SomaLogic investors are to receive 1.11 common shares of Standard BioTools stock for each SomaLogic common share they hold. When the merger closes, SomaLogic ...Analyst Recommendations on SomaLogic, Inc. Canaccord Genuity Downgrades SomaLogic to Hold From Buy, Cuts Price Target to $2.50 From $5. Sep. 25. MT. Canaccord Genuity Adjusts Price Target on SomaLogic to $5 From $6, Maintains Buy Rating. Mar. 29.Summary of all time highs, changes and price drops for SomaLogic; Historical stock prices; Current Share Price: US$2.71: 52 Week High: US$3.79: 52 …SomaLogic shareholders will receive 1.11 shares of Standard BioTools common stock for each share of SomaLogic common stock owned. Upon the close of the deal, Standard BioTools shareholders will ...

The ETF added to its position in the biotech stock earlier this month and now owns nearly 12.6 million shares, valued at close to $29 million. SomaLogic is a pioneer in proteomics, the study of ...

SomaLogic (Nasdaq: SLGC) is fostering the discovery of effective and safer treatments for patients in need while empowering more accurate diagnosis, prevention, and treatment of disease through the next generation of proteomics. Powered by an industry-leading technology platform comprised of both assay services and diagnostics in …

SomaLogic boasts industry-leading reliability metrics that include sensitivity, specificity, and reproducibility, with coefficients of variation ~5%. Most protein assays excel in one or two areas. The SomaScan Assay is the first and only platform that enables 11,000 protein measurements from a 55-µL sample.Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the SSomaLogic, Inc. (SLGCW) NasdaqGM - NasdaqGM Real Time Price. Currency in USD Follow 0.1500 0.0000 (0.00%) At close: 10:20AM EST 1d 5d 1m 6m YTD 1y 5y Max Full screen Trade prices are not sourced...Planned merger with SomaLogic activates strategic M&A thesis. SOUTH SAN FRANCISCO, Calif., Nov. 07, 2023 (GLOBE NEWSWIRE) -- BioTools Inc. (“SBI” or the “Company”) (Nasdaq: LAB), driven by ...Operator: Good afternoon, and welcome to SomaLogic's Third Quarter 2023 Earnings Conference Call. [Operator Instructions] As a reminder, this call is being recorded for replay purposes. - Part 2Dec 4, 2023 · Standard BioTools and SomaLogic to Combine in All-Stock Merger Creating a Diversified Leader in Life Sciences Tools. GlobeNewswire 61d. Start Trading >> Plus500. 81% of retail CFD accounts lose money. Stockholder, Stake, Shares owned, Total value ($), Shares bought / sold, Total change. ARK Investment Management LLC, 6.88%, 12,983,002, 28,952,094 ...Mar 28, 2023 · SomaLogic projects revenue for the full year 2023 to range from $80 million to $84 million. Webcast and Conference Call Details. SomaLogic will host a conference call at 4:30 p.m. ET on Tuesday, March 28, 2023 to discuss its fourth quarter 2022 financial results. Those interested in listening to the conference call should register online here ... About the SLGC stock forecast. As of 2023 November 13, Monday current price of SLGC stock is 2.480$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).. Somalogic stock price has been showing a declining tendency so we believe that similar market segments were not very popular in the given …Nov 22, 2023 · Why SomaLogic Stock Dived by 10% on Wednesday msn.com - October 4 at 6:56 PM: Shareholder Alert: Ademi LLP investigates whether SomaLogic, Inc. has obtained a Fair Price in its transaction with Standard BioTools benzinga.com - October 4 at 1:56 PM: SLGC Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of SomaLogic, Inc. Upon the terms and subject to the conditions set forth in the Merger Agreement, at the effective time of the Merger, each share of common stock, par value $0.0001 per share, of SomaLogic issued and outstanding (“SomaLogic Stock”) will be converted into the right to receive 1.11 (the “Exchange Ratio”) shares of common stock, …

Somalogic story: Study finds proteomic risk scores for cardiovascular disease from SomaSignal Cardio DM tests could support physicians in managing patient outcomes and other headlines for Somalogic StockBOULDER — SomaLogic Inc. (Nasdaq: SLGC) and California-based Standard BioTools Inc. (Nasdaq: LAB) have agreed to an all-stock merger deal that is expected to result in a combined company valued at more than $1 billion. Existing executives with both companies will lead the combined organization, which will carry the …"Based on stock prices, people don't seem to like this deal," said Kyle Mikson, an analyst with Canaccord Genuity who covers SomaLogic. "People knew Standard BioTools was going to buy something and SomaLogic makes a kind of sense, but I'm sure SomaLogic investors wanted a better premium and Standard BioTools investors wanted a more proven asset ...Instagram:https://instagram. inzy stock forecastvleo stock pricehow to practice options tradingvtip vanguard Under the terms of the agreement, which was unanimously approved by the participating members of the boards of directors of both companies, SomaLogic … best mechanical breakdown insurance for used carsiot samsara Approximate date of commencement of proposed sale to the public: As soon as practicable after this registration statement becomes effective and all other conditions to the transactions contemplated by the Merger Agreement described in the included proxy statement/prospectus have been satisfied or waived.. If the securities being registered on …Planned merger with SomaLogic activates strategic M&A thesis. SOUTH SAN FRANCISCO, Calif., Nov. 07, 2023 (GLOBE NEWSWIRE) -- BioTools Inc. (“SBI” or the “Company”) (Nasdaq: LAB), driven by ... xlk holdings list hace 8 horas ... ... SomaLogic Investor Relations at [email protected]. No Offer or ... Stock Picks. More Stock Picks · 3 Dividend Stocks for December 2023.SomaLogic (Nasdaq: SLGC) is fostering the discovery of effective and safer treatments for patients in need while empowering more accurate diagnosis, prevention, and treatment of disease through the next generation of proteomics. Powered by an industry-leading technology platform comprised of both assay services and diagnostics in combination ...